- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 168 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2024
- 180 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
The Follicle Stimulating Hormone Test (FSH) is a type of in vitro diagnostic test used to measure the amount of FSH in a patient's blood. FSH is a hormone produced by the pituitary gland that helps regulate the reproductive system. The FSH test is used to diagnose infertility, ovarian cysts, and other reproductive disorders. It is also used to monitor the effectiveness of fertility treatments.
The FSH test market is a growing segment of the in vitro diagnostics industry. It is driven by the increasing prevalence of infertility and other reproductive disorders, as well as the growing demand for fertility treatments. The market is also driven by technological advancements in the field, such as the development of automated FSH testing systems.
Some of the major players in the FSH test market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more